Prevalence and Determinants of Obesity in PKU Patients
NCT07703020 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-07-14
Summary
This observational cross-sectional multicenter study aims to assess the prevalence of overweight and obesity in adult patients with phenylketonuria (PKU) and to identify associated risk factors. Adult PKU patients followed in metabolic centers in Switzerland and Austria will be evaluated using clinical data, laboratory parameters, and standardized questionnaires addressing diet, physical activity, and psychological factors. The study seeks to better understand contributors to weight gain in this population to inform preventive strategies.
Conditions
- Phenylketonuria (PKU)
Sponsors & Collaborators
-
Christel Tran
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-01
- Primary Completion
- 2028-02-01
- Completion
- 2029-02-01
Countries
- Switzerland
Study Locations
More Related Trials
-
Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
NCT00375089 ·Status: COMPLETED
-
Natural History Clinical Study in Adult PKU
NCT04768348 ·Status: TERMINATED
-
Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase
NCT03856203 ·Status: COMPLETED
-
Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
NCT04404530 ·Status: RECRUITING
-
Metabolic Screening in Patients With Donnai-Barrow Syndrome
NCT01509287 ·Status: COMPLETED
-
A Screening Study Evaluating Disease Status of Gaucher Type I Patients
NCT00795197 ·Status: WITHDRAWN
-
Retrospective and Prospective Observational Study of MRI Changes in Bone and Visceral Lesions of Patients With Type 1 Gaucher Disease Treated With VPRIV® (Velaglucerase Alfa)
NCT03333447 ·Status: COMPLETED
-
A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190
NCT04455230 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
NCT02972580 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Study of Families Affected by Paget's Disease of Bone
NCT00747994 ·Status: COMPLETED
-
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
NCT06328608 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Fasting Tolerance in MCADD-infants
NCT03761693 ·Status: UNKNOWN ·Phase: NA
-
Pyruvate Kinase Deficiency Natural History Study
NCT02053480 ·Status: COMPLETED
-
Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.
NCT02078401 ·Status: UNKNOWN
-
Retrospective Study of Adult Patients With Inborn Errors of Metabolism in Switzerland
NCT03534752 ·Status: COMPLETED
-
A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children
NCT07511920 ·Status: NOT_YET_RECRUITING
-
Acute Nutritional Ketosis in GSD IIIa
NCT03011203 ·Status: COMPLETED ·Phase: NA
-
Genotype/Phenotype Correlation With Focus on Lung Function in Primary Ciliary Dyskinesia (PCD)
NCT04717115 ·Status: UNKNOWN
-
Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.
NCT01963897 ·Status: COMPLETED
-
X-linked Hypophosphatemia and FGF21
NCT03596554 ·Status: COMPLETED
-
The U.K. NorthStar Clinical Network
NCT06711692 ·Status: NOT_YET_RECRUITING
-
Ten Year Follow-up in FSHD: the FOCUS 3 Study
NCT06911190 ·Status: RECRUITING
-
Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease
NCT03566017 ·Status: COMPLETED ·Phase: PHASE3
-
Dentatorubral-pallidoluysian Atrophy Natural History and Biomarkers Study
NCT06273150 ·Status: RECRUITING
-
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
NCT06941025 ·Status: RECRUITING